Craneware Regulatory News (CRW)

Craneware plc

("Craneware" or the "Company")

Director Shareholding

31 January 2017 - Craneware plc (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, has been informed that Keith Neilson, CEO of the Company, yesterday transferred 49,800 ordinary shares of 1 pence each in the Company ("Ordinary Shares") at a price of 1,305 pence per share. Mr. Neilson transferred the shares from his holding to the Neilson Family Foundation, a charity trust set up for the future benefit of medical research and Young People's charities, to which Mr. Neilson is the sole adviser with regards to voting and holding rights.

Following this transaction, Mr. Neilson's beneficial interest in Craneware has reduced to 3,459,718 Ordinary Shares, representing approximately 12.8% of the Company's issued Ordinary Share capital.

For further information, please contact:

 About Craneware

Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.

Craneware is the leader in automated value cycle solutions that help US healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware has its headquarters in Edinburgh, Scotland with offices in Atlanta, Boston and Phoenix employing over 200 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.